Omics

Niels Lynnerup explains the discipline of paleopathology and what benefits it has to offer pathology in the clinic or in the research laboratory

How combining their efforts with those of the pharmaceutical industry can help pathologists make a business case for AI

Sitting Down With Oliver Fiehn, Director of NIH West Coast Metabolomics Center

How to get proteomics back on track

Researchers from Penn State examine the 16p11.2 deletion for its role in neurodevelopmental disorders and related phenotypes

Looking at miRNA expression levels may improve our ability to subtype bladder cancers and provide the most appropriate and effective treatment

Broad NGS panels work well for cancer screening, but for monitoring, we need tools that are less expensive and more targeted

A roundup of interesting stories surrounding pathology

iPSC-based and genome editing approaches to the study of cardiac channelopathies may be the next step toward personalizing diagnosis and treatment

Inertial microfluidics for fetal screening